Davenport & CO LLC Cognition Therapeutics Inc Transaction History
Davenport & CO LLC
- $17.5 Billion
- Q3 2025
A detailed history of Davenport & CO LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Davenport & CO LLC holds 2,689,336 shares of CGTX stock, worth $4.98 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,689,336Holding current value
$4.98 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
57Shares Held
16.3MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$11.1 Million2.56% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$4.08 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$2.41 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA702KShares$1.3 Million0.0% of portfolio
-
Chescapmanager LLC Baltimore, MD503KShares$931,0290.02% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $42M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...